AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Edax 1.5mg Injection

Prescription Icon
Prescription Required

Marketer

Axis Life Science Pvt Ltd

Salt Composition

Edaravone (1.5mg)

Overview Edax 1.5mg Injection

Nervana 1.5mg Injection combats amyotrophic lateral sclerosis (ALS), a debilitating neuromuscular condition causing muscle weakness and functional impairment. Its antioxidant properties mitigate nerve cell damage, thereby slowing disease advancement. Administered intravenously by a healthcare provider, Nervana 1.5mg Injection is reserved for patients unable to take oral medication. Strictly adhere to your physician's prescribed dosage and schedule; if a dose is missed, administer it promptly upon recollection. Commonly reported side effects include headache, ecchymosis, and gait abnormalities. Local injection site reactions, such as pain, erythema, or edema, may occur but are typically transient and self-limiting. Persistent or troublesome side effects warrant medical consultation. Seek immediate medical attention for allergic reactions—manifested as pruritus, facial or lingual swelling—following injection.

Uses of Edax 1.5mg Injection

Lou Gehrig's disease

Major Benefits of Edax 1.5mg Injection:

The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Edax 1.5mg Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Edax 1.5mg Injection:

This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.

How Edax 1.5mg Injection works:

Edax 1.5mg Injection offers antioxidant, neuroprotective, and nootropic benefits. Its mechanism involves mitigating nerve damage from free radical attack, thereby slowing the advancement of amyotrophic lateral sclerosis (ALS) symptoms. This effect is achieved by restoring balance between antioxidants and free radicals within the brain, reducing oxidative stress.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Edax 1.5mg Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Edax 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible adverse effects prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Edax 1.5mg Injection use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability may be affected by Edax 1.5mg Injection; however, the extent of this effect is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Edax 1.5mg Injection to individuals with renal impairment. Seek medical advice from your physician.

LiverLiverCAUTION

Individuals with severe hepatic impairment should use Edax 1.5mg Injection cautiously; dosage modification may be necessary. Consult a physician for guidance. Data regarding Edax 1.5mg Injection use in such patients is limited. Dosage alteration is not advised for those with mild to moderate liver dysfunction.

What if you forget to take Edax 1.5mg Injection :

NA

Facts to Know About Edax 1.5mg Injection

LabelValue
Type of Compound Pyrazolone-based compounds
Potential for Dependence None.
Medication Classification Nervous system medications
Mechanism of Action Cognitive enhancer

FAQs on Edax 1.5mg Injection

Edax 1.5mg Injection may cause confusion, headache, and gait disturbances as its most frequent adverse effects. Less common side effects include skin reactions such as rash and pruritus, respiratory symptoms like dyspnea, chest constriction, wheezing, and cough (particularly in asthmatics), and the development of fungal infections.
Administered intravenously by a healthcare provider in a clinical setting, Edax 1.5mg Injection, a liquid solution, is infused over a one-hour period. For the initial 28-day treatment cycle, daily injections are typically given for the first fourteen days. Subsequent 28-day cycles usually involve daily injections for the first ten days. Dosage frequency adjustments for Edax 1.5mg Injection are determined by the physician based on individual patient response.
Riluzole 1.5mg injection is indicated for the management of amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease characterized by the gradual deterioration of motor neurons, leading to muscle atrophy and weakness. Riluzole 1.5mg injection exerts its therapeutic effect by decelerating the neurodegeneration linked to the progression of ALS.
Consult your physician or pharmacist about any allergies to edaravone, other drugs, sodium bisulfite, or Edax 1.5mg Injection components. Disclose all current and planned medication use, including prescription and over-the-counter drugs, vitamins, and supplements, to your doctor. Dosage adjustments or close monitoring for adverse reactions may be necessary. Report any history of asthma, pregnancy (current or planned), or breastfeeding to your doctor. Contact your doctor immediately should you become pregnant during edaravone treatment.
Research has yet to determine whether ALS is preventable. Nevertheless, understanding associated risk factors may lessen the likelihood of developing the condition. These factors encompass tobacco use and contact with pesticides and insecticides. Furthermore, evidence indicates a heightened ALS risk among military veterans.
Individuals of Caucasian and non-Hispanic descent exhibit the highest incidence of this disease. Between 5% and 10% of all cases are inherited, resulting from parental transmission. Onset can occur at any age, though symptoms typically emerge between ages 55 and 75. A slightly higher prevalence is observed in males compared to females; however, this disparity diminishes with increasing age. Research indicates a potential link between military service and increased risk, with veterans showing a 1.5 to 2-fold higher likelihood of developing the condition, possibly due to exposure to toxins during military service.
Studies propose a link between toxin exposure in combat or intense physical exertion and a heightened ALS risk among veterans and athletes.
Initial ALS manifestations can involve muscle fasciculations in the limbs or tongue, muscle spasms, muscle stiffness (spasticity), and weakening of arm, leg, neck, or diaphragm muscles. Speech may become slurred or nasal, and swallowing may become challenging. The onset often presents as hand or arm weakness, hindering simple actions like fastening clothing, writing, or manipulating keys. Alternatively, leg weakness may be the initial symptom, causing gait difficulties, increased tripping, or stumbling.
Edax 1.5mg Injection
369
MRP 450
18% off